GRCE

NASDAQ · Equity

Grace Therapeutics, Inc.

US Healthcare Biotechnology

Latest week
29 May 2026
Close
2.570000
Fair value
3.235011
Expectation
Positive 60.20%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
2.57
12-Week Change
-38.81%
Trend Signal
Inactive
Expectation
Positive 60.20%
Signal Weeks
7 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-37.16
Market Dynamics
-0.85

Over the latest 12 completed weeks ending 2026-05-29, GRCE fell 38.81%, moving from 4.20 to 2.57. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 7 of the last 12 weeks. Relative Strength is -37.16 and has softened across the 12-week window. Market Dynamics is -0.85 on the latest week. Expectation is positive at 60.20%.